Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis

References

• Lukes R, Butler J, Hicks E. Natural history of Hodgkin's disease as related to its pathological picture. Cancer 1966; 19: 317–344
   Web of Science ®Google Scholar
• Benharroch D, Stein H, Peh S-C. Lymphocyte-depleted classical Hodgkin lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, S H Swerdlow, E Campo, N L Harris, S E Jaffe, S A Pileri, H Stein, J Thiele, J W Vardiman. IARC, Lyon 2008; 334
   Google Scholar
• Delsol G, Gatter K C, Stein H, Erber W N, Pulford K A, Zinne K, Mason D Y. Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms. Lancet 1984; 2: 1124–1129
   PubMed Web of Science ®Google Scholar
• Hall P A, D'Ardenne A J. Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. J Clin Pathol 1987; 40: 1298–1304
   PubMed Web of Science ®Google Scholar
• Pinkus G S, Pinkus J L, Langhoff E, Matsumura F, Yamashiro S, Mosialos G, Said J W. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?. Am J Pathol 1997; 150: 543–562
   PubMed Web of Science ®Google Scholar
• Schmid C, Pan L, Diss T, Isaacson P. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol 1991; 139: 701–707
   PubMed Web of Science ®Google Scholar
• Stein H, Lennert K, Feller A, Mason D. Immunological analysis of tissue sections in diagnosis of lymphoma. Recent Advances in Haematology, A V Hoffbrand. Churchill Livingstone, New York 1985; 127–169
   Google Scholar
• Strauchen J A. Leucocyte common antigen in the differential diagnosis of Hodgkin's disease. Hematol Oncol 1989; 7: 149–153
   PubMed Web of Science ®Google Scholar
• Zukerberg L, Collins A, Ferry J, Harris N. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease. Am J Pathol 1991; 139: 475–483
   PubMed Web of Science ®Google Scholar
• Steimle-Grauer S A, Tinguely M, Seada L, Fellbaum C, Hansmann M L. Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma. Virchows Arch 2003; 442: 284–293
   PubMed Web of Science ®Google Scholar
• Torlakovic E, Torlakovic G, Nguyen P L, Brunning R D, Delabie J. The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker. Am J Surg Pathol 2002; 26: 1343–1350
   PubMed Web of Science ®Google Scholar
• Ponzoni M, Arrigoni G, Doglioni C. New transcription factors in diagnostic hematopathology. Adv Anat Pathol 2007; 14: 25–35
   PubMed Web of Science ®Google Scholar
• Carbone A, Gloghini A, Aldinucci D, Gattei V, Dalla-Favera R, Gaidano G. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease. Br J Haematol 2002; 117: 366–372
   PubMed Web of Science ®Google Scholar
• Foss H-D, Reusch R, Demel G, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Blood 1999; 94: 3108–3113
   PubMed Web of Science ®Google Scholar
• Saez A I, Artiga M J, Sanchez-Beato M, Sanchez-Verde L, Garcia J F, Camacho F I, Franco R, Piris M A. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas. Mod Pathol 2002; 15: 211–220
   PubMed Web of Science ®Google Scholar
• Stein H, Marafioti T, Foss H D, Laumen H, Hummel M, Anagnostopoulos I, Wirth T, Demel G, Falini B. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001; 97: 496–501
   PubMed Web of Science ®Google Scholar
• Pileri S A, Ascani S, Leoncini L, Sabattini E, Zinzani P L, Piccaluga P P, Pileri A, Jr, Giunti M, Falini B, Bolis G B, Stein H. Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol 2002; 55: 162–176
   PubMed Web of Science ®Google Scholar
• Cossman J, Annunziata C M, Barash S, Staudt L, Dillon P, He W W, Ricciardi-Castagnoli P, Rosen C A, Carter K C. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood 1999; 94: 411–416
   PubMed Web of Science ®Google Scholar
• Marafioti T, Hummel M, Foss H D, Laumen H, Korbjuhn P, Anagnostopoulos I, Lammert H, Demel G, Theil J, Wirth T, Stein H. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443–1450
   PubMed Web of Science ®Google Scholar
• van Dongen J J, Langerak A W, Bruggemann M, Evans P A, Hummel M, Lavender F L, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken J H, Droese J, Gonzalez D, Bastard C, White H E, Spaargaren M, Gonzalez M, Parreira A, Smith J L, Morgan G J, Kneba M, Macintyre E A. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257–2317
   PubMed Web of Science ®Google Scholar
• Greer J P, Kinney M C, Cousar J B, Flexner J M, Dupont W D, Graber S E, Greco F A, Collins R D, Stein R S. Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patients. Am J Med 1986; 81: 208–214
   PubMed Web of Science ®Google Scholar
• Kant J, Hubbard S, Longo D, Simon R, DeVita V, Jaffe E. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease. J Clin Oncol 1986; 4: 284–294
   PubMed Web of Science ®Google Scholar
• Neiman R S, Rosen P J, Lukes R J. Lymphocyte-depletion Hodgkin's disease. A clinicopathological entity. N Engl J Med 1973; 288: 751–755
   PubMed Web of Science ®Google Scholar
• Mhawech-Fauceglia P, Saxena R, Zhang S, Terracciano L, Sauter G, Chadhuri A, Herrmann F R, Penetrante R. Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis. J Clin Pathol 2007; 60: 709–714
   PubMed Web of Science ®Google Scholar
• Garcia-Cosio M, Santon A, Martin P, Camarasa N, Montalban C, Garcia J F, Bellas C. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. Mod Pathol 2004; 17: 1531–1538
   PubMed Web of Science ®Google Scholar
• Tzankov A, Zimpfer A, Pehrs A C, Lugli A, Went P, Maurer R, Pileri S, Dirnhofer S. Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod Pathol 2003; 16: 1141–1147
   PubMed Web of Science ®Google Scholar
• McCune R C, Syrbu S I, Vasef M A. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays. Mod Pathol 2006; 19: 1010–1018
   PubMed Web of Science ®Google Scholar
• Browne P, Petrosyan K, Hernandez A, Chan J A. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am J Clin Pathol 2003; 120: 767–777
   PubMed Web of Science ®Google Scholar
• Tzankov A, Bourgau C, Kaiser A, Zimpfer A, Maurer R, Pileri S A, Went P, Dirnhofer S. Rare expression of T-cell markers in classical Hodgkin's lymphoma. Mod Pathol 2005; 18: 1542–1549
   PubMed Web of Science ®Google Scholar
• Stein H, Delsol G, Pileri S A, Weiss L M, Poppema S, Jaffe E S. Classical Hodgkin lymphoma, introduction. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, S H Swerdlow, E Campo, N L Harris, S E Jaffe, S A Pileri, H Stein, J Thiele, J W Vardiman. IARC, Lyon 2008; 326–329
   Google Scholar
• Gandhi M K, Tellam J T, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol 2004; 125: 267–281
   PubMed Web of Science ®Google Scholar
• Chute D J, Cousar J B, Mahadevan M S, Siegrist K A, Silverman L M, Stoler M H. Detection of immunoglobulin heavy chain gene rearrangements in classic Hodgkin lymphoma using commercially available BIOMED-2 primers. Diagn Mol Pathol 2008; 17: 65–72
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Stein H, Swerdlow S H, Campo E, Pileri S A, Harris N L. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, S H Swerdlow, E Campo, N L Harris, S E Jaffe, S A Pileri, H Stein, J Thiele, J W Vardiman. IARC, Lyon 2008; 267–268
   Google Scholar